Data_Sheet_1_Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.pdf

<p>Background: Little is known regarding the clinical impact of treatment and treatment duration of probiotic VSL#3 on gut and microbiome function in irritable bowel syndrome (IBS). As part of a safety trial, we assessed the effect of VSL#3 treatment duration on abdominal pain, stooling, gut p...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Prapaporn Boonma (80485) (author)
مؤلفون آخرون:	Jordan M. Shapiro (11464489) (author), Emily B. Hollister (156772) (author), Shyam Badu (1285002) (author), Qinglong Wu (195500) (author), Erica M. Weidler (8472927) (author), Bincy P. Abraham (11464492) (author), Sridevi Devaraj (7479887) (author), Ruth Ann Luna (8313483) (author), James Versalovic (158351) (author), Margaret M. Heitkemper (9131061) (author), Tor C. Savidge (726121) (author), Robert J. Shulman (2015980) (author)
منشور في:	2021
الموضوعات:	Medicine Cell Biology Cancer Anaesthesiology Physiology not elsewhere classified irritable bowel syndrome VSL#3 probiotic permeability microbiome bile acids
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Data_Sheet_1_Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.pdf

مواد مشابهة